Jbm (Healthcare) Ltd
HKEX:2161
Intrinsic Value
JBM (Healthcare) Ltd. functions as an investment holding company. [ Read More ]
The intrinsic value of one Jbm (Healthcare) Ltd stock under the Base Case scenario is 1.23 HKD. Compared to the current market price of 0.88 HKD, Jbm (Healthcare) Ltd is Undervalued by 28%.
Valuation Backtest
Jbm (Healthcare) Ltd
Run backtest to discover the historical profit from buying and selling Jbm (Healthcare) Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Jbm (Healthcare) Ltd
Current Assets | 377.8m |
Cash & Short-Term Investments | 114.2m |
Receivables | 176.9m |
Other Current Assets | 86.7m |
Non-Current Assets | 1.1B |
Long-Term Investments | 30.5m |
PP&E | 152.5m |
Intangibles | 849.4m |
Other Non-Current Assets | 23m |
Current Liabilities | 221.9m |
Accounts Payable | 26.2m |
Accrued Liabilities | 22.5m |
Other Current Liabilities | 173.2m |
Non-Current Liabilities | 208.6m |
Long-Term Debt | 62.9m |
Other Non-Current Liabilities | 145.7m |
Earnings Waterfall
Jbm (Healthcare) Ltd
Revenue
|
610.3m
HKD
|
Cost of Revenue
|
-319.2m
HKD
|
Gross Profit
|
291.1m
HKD
|
Operating Expenses
|
-165.8m
HKD
|
Operating Income
|
125.3m
HKD
|
Other Expenses
|
-27.3m
HKD
|
Net Income
|
98m
HKD
|
Free Cash Flow Analysis
Jbm (Healthcare) Ltd
Profitability Score
Profitability Due Diligence
Jbm (Healthcare) Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Jbm (Healthcare) Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jbm (Healthcare) Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Jbm (Healthcare) Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jbm (Healthcare) Ltd
Shareholder Return
Price
Jbm (Healthcare) Ltd
Average Annual Return | -29.79% |
Standard Deviation of Annual Returns | 28.59% |
Max Drawdown | -79% |
Market Capitalization | 784.6m HKD |
Shares Outstanding | 891 572 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.
Contact
IPO
Employees
Officers
The intrinsic value of one Jbm (Healthcare) Ltd stock under the Base Case scenario is 1.23 HKD.
Compared to the current market price of 0.88 HKD, Jbm (Healthcare) Ltd is Undervalued by 28%.